click below
click below
Normal Size Small Size show me how
Pharm CHF
Pharmacology 9/16/08
| Question | Answer |
|---|---|
| CHF Risk Factors in Men | Cigarette smoking in younger but not older than 65 years HTN and DM (4 fold increase < 65) ECG evidence of LVH (15 fold increase <65) |
| CHF Risk Factors in Women (under age 65) | HTN (3 fold increase) DM (5 fold increase) LVH (15 fold increase) |
| General Risk Factors for Both Genders | Obesity Increased total cholesterol ProteinuriaECG evidence of intraventricular conduction disturbances or non specific repolarization abnormalities |
| Pre-existing conditions that can cause an increase in pressure or volume overload of the mycardium lead to heart failure | HTN Valvular Heart Disease CAD (myocardial infarction) Cardiomyopathies Pericardial Disease Infectious etiologies (viral myocarditis) |
| Severity of Heart Failure Classification Class I | Asymptomatic Left ventricular dysfunction. No limitation of physical activity. No fatigue, dyspnea, or palpitations with ordinary activity |
| Severity of Heart Failure Classification Class II | Slight limitation of physical activity. Although comfortable at rest, fatigue, dyspnea, or palpitations occur with ordinary physical activity (mod. To max exertion) |
| Severity of Heart Failure Classification Class III | Marked limitation of physical activity. Although comfortable at rest, fatigue, dyspnea, or palpitations occur with less than ordinary activity (minimal exertion) |
| Severity of Heart Failure Classification Class IV | Unable to carry on physical activity without discomfort or worsening symptoms. Fatigue, dyspnea, or palpitations occur at rest |
| Symptoms of Left sided Heart Failure | Dyspnea Orthopnea Fatigue Paroxysmal nocturnal dyspnea |
| Symptoms of Right sided Heart Failure | Peripheral edema Right upper quadrant discomfort (hepatic enlargement) |
| Clinical physical findings | Diaphoresis Tachycardia Tachypnea Pulmonary rales, wheezes Jugular venous distention Hepatomegaly Peripheral edema |
| What is the primary goal of tx? | Remove the underlying cause |
| Three factors that help control CHF | Improving cardiac performance Reducing cardiac workload Controlling Na and water retention |
| Treatment components | Dietary considerations (Na restriction) Physical conditioning (exercise rehab.) Drug therapy |
| Precipitating and Underlying Disease or conditions | Infection, Fever, Fluid overload, Increased dietary salt intake, Uncontrolled HTN, Cardiac Arrhythmias, Thiamine deficiency, Myocardial Ischemia, Renal failure, Thyrotoxicosis, Pulomonary Embolism, Anemia, High environmental temperature, Respiratory insuf |
| 5 Drug Classes used in treatment | Diuretics Digoxin ACE inhibitors Beta blockers Vasodilators |
| Nitroprusside (Nitropress) | Vasodilator Ind: Overt Heart Failure with severe HTN, valvular heart disease, or cardiac surgery MOA: Inc CO, reduce peripheral resistance ADR: HA, GI distress, may get build up of metabolites during or in pts with renal dysfunction |
| Nitroglycerin (nitrostat, minitran, nitro-dur) | Vasodilator Ind: Left ventricular dysfunction resulting from unstable coronary insufficiency MOA: decreases left ventricular pressure and systemic vascular resistance; dilates coronary arteries ADR: HA, hypotension, nitrate tolerance requiring upward f |
| Minoxidil | Vasodilator Ind: Severe HTN (Not used in CHF) MOA: direct vasodilation of the arterioles with decreased systemic vascular resistance ADR: EKG changes, CHF, tachycardia |
| Hydralazine (Apresoline) | Vasodilator Ind: CHF and moderate to severe HTN MOA: direct vasodilation of the arterioles with decreased systemic vascular resistance ADR: HA, nausea, dizziness, tachycardia, lupus like syndrome |
| Minoxidil | Vasodilator Ind: Severe HTN (Not used in CHF) MOA: direct vasodilation of the arterioles with decreased systemic vascular resistance ADR: EKG changes, CHF, tachycardia |
| Isosorbide Dinitrate (Dilatrate) | Vasodilators Ind: CHF; proven effective in combination with hydralazine MOA: decreases left ventricular pressure and systemic vascular resistance; dilates coronary arteries ADR: HA, hypotension, flushing |